MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. EV/EBITDA Ratio 2011-2026 | PRAH
Annual EV/EBITDA Ratio PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 20.8 | 15.7 | 17.8 | 20.1 | 14.9 | 13.8 | 12.9 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.8 | 12.9 | 16.6 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 18.99 | 5.91 % | $ 201 M |  China |
 |
Agilent Technologies
A
|
27.4 | $ 120.9 | 2.89 % | $ 36.8 B |  USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 17.33 | 2.97 % | $ 923 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
3.62 | $ 1.44 | -0.69 % | $ 1.92 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 24.52 | 4.21 % | $ 681 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
22 | $ 181.97 | 2.04 % | $ 9.02 B | USA |
 |
Interpace Biosciences
IDXG
|
-6.02 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 199.74 | 1.98 % | $ 142 B | USA |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
30.7 | $ 516.16 | 2.98 % | $ 14.9 B | USA |
 |
Illumina
ILMN
|
70.5 | $ 130.2 | 2.55 % | $ 20.7 B | USA |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 4.76 | 3.7 % | $ 441 M | USA |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 15.74 | 2.88 % | $ 476 M | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 8.24 | 3.0 % | $ 1.06 B | USA |
 |
Guardant Health
GH
|
-28.8 | $ 86.09 | 4.71 % | $ 10.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
-19.5 | $ 210.73 | 4.37 % | $ 20.7 B | USA |
 |
Anixa Biosciences
ANIX
|
-2.25 | $ 2.83 | -0.7 % | $ 91.8 K | USA |
 |
Biomerica
BMRA
|
-6.24 | $ 2.04 | -1.92 % | $ 4.69 M | USA |
 |
ICON Public Limited Company
ICLR
|
38 | $ 113.3 | 2.65 % | $ 9.35 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 267.36 | 1.2 % | $ 22.2 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
55.6 | $ 29.13 | 2.03 % | $ 20 B | Niderland |
 |
Celcuity
CELC
|
-2.38 | $ 120.79 | 0.32 % | $ 5.65 B | USA |
 |
Neogen Corporation
NEOG
|
40.3 | $ 9.41 | 2.95 % | $ 2.04 B | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 83.46 | 2.19 % | $ 5.63 B | USA |
 |
Senseonics Holdings
SENS
|
-13.8 | $ 6.8 | 1.19 % | $ 284 M | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | Israel |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 193.24 | 0.17 % | $ 21.4 B | USA |
 |
Soleno Therapeutics
SLNO
|
0.12 | $ 52.64 | - | $ 2.68 B | USA |
 |
ENDRA Life Sciences
NDRA
|
0.831 | $ 5.06 | -2.5 % | $ 3.98 M | USA |
 |
Neuronetics
STIM
|
-1.45 | $ 1.43 | 2.52 % | $ 94.3 M | USA |
 |
National Research Corporation
NRC
|
21 | $ 17.02 | 1.19 % | $ 381 M | USA |